There’s no cure for Alzheimer’s disease. But that hasn’t stopped drug companies from promising the public they are on the cusp of a miracle drug that will suddenly cure this life-shattering disease.
Last June, the U.S. Food and Drug Administration (FDA) approved the use of the experimental drug, aducanumab for early phases of Alzheimer’s disease – the first time FDA-approved therapy since 2003.… Read More